114 related articles for article (PubMed ID: 19836351)
1. Deregulation of DUSP activity in EGFR-mutant lung cancer cell lines contributes to sustained ERK1/2 signaling.
Britson JS; Barton F; Balko JM; Black EP
Biochem Biophys Res Commun; 2009 Dec; 390(3):849-54. PubMed ID: 19836351
[TBL] [Abstract][Full Text] [Related]
2. Metalloprotease-dependent activation of EGFR modulates CD44
Wise R; Zolkiewska A
Breast Cancer Res Treat; 2017 Nov; 166(2):421-433. PubMed ID: 28791489
[TBL] [Abstract][Full Text] [Related]
3. Dual specificity phosphatase (DUSP)-4 is induced by platelet-derived growth factor -BB in an Erk1/2-, STAT3- and p53-dependent manner.
Yin R; Eger G; Sarri N; Rorsman C; Heldin CH; Lennartsson J
Biochem Biophys Res Commun; 2019 Nov; 519(3):469-474. PubMed ID: 31526568
[TBL] [Abstract][Full Text] [Related]
4. Regulation of angiopoietin-1/Tie-2 receptor signaling in endothelial cells by dual-specificity phosphatases 1, 4, and 5.
Echavarria R; Hussain SN
J Am Heart Assoc; 2013 Dec; 2(6):e000571. PubMed ID: 24308939
[TBL] [Abstract][Full Text] [Related]
5. Analysis of phosphatases in ER-negative breast cancers identifies DUSP4 as a critical regulator of growth and invasion.
Mazumdar A; Poage GM; Shepherd J; Tsimelzon A; Hartman ZC; Den Hollander P; Hill J; Zhang Y; Chang J; Hilsenbeck SG; Fuqua S; Kent Osborne C; Mills GB; Brown PH
Breast Cancer Res Treat; 2016 Aug; 158(3):441-54. PubMed ID: 27393618
[TBL] [Abstract][Full Text] [Related]
6. VEGF autoregulates its proliferative and migratory ERK1/2 and p38 cascades by enhancing the expression of DUSP1 and DUSP5 phosphatases in endothelial cells.
Bellou S; Hink MA; Bagli E; Panopoulou E; Bastiaens PI; Murphy C; Fotsis T
Am J Physiol Cell Physiol; 2009 Dec; 297(6):C1477-89. PubMed ID: 19741200
[TBL] [Abstract][Full Text] [Related]
7. Oncogenic KRAS and BRAF activation of the MEK/ERK signaling pathway promotes expression of dual-specificity phosphatase 4 (DUSP4/MKP2) resulting in nuclear ERK1/2 inhibition.
Cagnol S; Rivard N
Oncogene; 2013 Jan; 32(5):564-76. PubMed ID: 22430215
[TBL] [Abstract][Full Text] [Related]
8. Profiling of residual breast cancers after neoadjuvant chemotherapy identifies DUSP4 deficiency as a mechanism of drug resistance.
Balko JM; Cook RS; Vaught DB; Kuba MG; Miller TW; Bhola NE; Sanders ME; Granja-Ingram NM; Smith JJ; Meszoely IM; Salter J; Dowsett M; Stemke-Hale K; González-Angulo AM; Mills GB; Pinto JA; Gómez HL; Arteaga CL
Nat Med; 2012 Jul; 18(7):1052-9. PubMed ID: 22683778
[TBL] [Abstract][Full Text] [Related]
9. Derlin-1 is overexpressed in non-small cell lung cancer and promotes cancer cell invasion via EGFR-ERK-mediated up-regulation of MMP-2 and MMP-9.
Dong QZ; Wang Y; Tang ZP; Fu L; Li QC; Wang ED; Wang EH
Am J Pathol; 2013 Mar; 182(3):954-64. PubMed ID: 23306155
[TBL] [Abstract][Full Text] [Related]
10. The role of dual‑specificity phosphatase 1 and protein phosphatase 1 in β2‑adrenergic receptor‑mediated inhibition of extracellular signal regulated kinase 1/2 in triple negative breast cancer cell lines.
Tuglu MM; Bostanabad SY; Ozyon G; Dalkiliç B; Gurdal H
Mol Med Rep; 2018 Jan; 17(1):2033-2043. PubMed ID: 29257221
[TBL] [Abstract][Full Text] [Related]
11. DUSP4 Inactivation Leads to Reduced Extracellular Signal‒Regulated Kinase Activity through Upregulation of DUSP6 in Melanoma Cells.
Kamada H; Yasuhira S; Shibazaki M; Amano H; Maesawa C
J Invest Dermatol; 2022 Sep; 142(9):2499-2507.e6. PubMed ID: 35189148
[TBL] [Abstract][Full Text] [Related]
12. DUSP4 is involved in the enhanced proliferation and survival of DUSP4-overexpressing cancer cells.
Ratsada P; Hijiya N; Hidano S; Tsukamoto Y; Nakada C; Uchida T; Kobayashi T; Moriyama M
Biochem Biophys Res Commun; 2020 Jul; 528(3):586-593. PubMed ID: 32505357
[TBL] [Abstract][Full Text] [Related]
13. An integrated genomic analysis of lung cancer reveals loss of DUSP4 in EGFR-mutant tumors.
Chitale D; Gong Y; Taylor BS; Broderick S; Brennan C; Somwar R; Golas B; Wang L; Motoi N; Szoke J; Reinersman JM; Major J; Sander C; Seshan VE; Zakowski MF; Rusch V; Pao W; Gerald W; Ladanyi M
Oncogene; 2009 Aug; 28(31):2773-83. PubMed ID: 19525976
[TBL] [Abstract][Full Text] [Related]
14. Statins affect ETS1-overexpressing triple-negative breast cancer cells by restoring DUSP4 deficiency.
Jung HH; Lee SH; Kim JY; Ahn JS; Park YH; Im YH
Sci Rep; 2016 Sep; 6():33035. PubMed ID: 27604655
[TBL] [Abstract][Full Text] [Related]
15. Multiple oncogenic changes (K-RAS(V12), p53 knockdown, mutant EGFRs, p16 bypass, telomerase) are not sufficient to confer a full malignant phenotype on human bronchial epithelial cells.
Sato M; Vaughan MB; Girard L; Peyton M; Lee W; Shames DS; Ramirez RD; Sunaga N; Gazdar AF; Shay JW; Minna JD
Cancer Res; 2006 Feb; 66(4):2116-28. PubMed ID: 16489012
[TBL] [Abstract][Full Text] [Related]
16. ICER evokes Dusp1-p38 pathway enhancing chemotherapy sensitivity in myeloid leukemia.
Pigazzi M; Manara E; Beghin A; Baron E; Tregnago C; Basso G
Clin Cancer Res; 2011 Feb; 17(4):742-52. PubMed ID: 21325296
[TBL] [Abstract][Full Text] [Related]
17. Nimbolide suppresses non-small cell lung cancer cell invasion and migration via manipulation of DUSP4 expression and ERK1/2 signaling.
Lin H; Qiu S; Xie L; Liu C; Sun S
Biomed Pharmacother; 2017 Aug; 92():340-346. PubMed ID: 28554129
[TBL] [Abstract][Full Text] [Related]
18. Sanguinarine inhibits growth and invasion of gastric cancer cells via regulation of the DUSP4/ERK pathway.
Zhang R; Wang G; Zhang PF; Zhang J; Huang YX; Lu YM; Da W; Sun Q; Zhu JS
J Cell Mol Med; 2017 Jun; 21(6):1117-1127. PubMed ID: 27957827
[TBL] [Abstract][Full Text] [Related]
19. DUSP 4 expression identifies a subset of colorectal cancer tumors that differ in MAPK activation, regardless of the genotype.
De Vriendt V; De Roock W; Di Narzo AF; Tian S; Biesmans B; Jacobs B; Budinska E; Sagaert X; Rossi S; D'Ario G; Delorenzi M; Simon I; Vecchione L; Tejpar S
Biomarkers; 2013 Sep; 18(6):516-24. PubMed ID: 23875912
[TBL] [Abstract][Full Text] [Related]
20. DUSP1 expression induced by HDAC1 inhibition mediates gefitinib sensitivity in non-small cell lung cancers.
Lin YC; Lin YC; Shih JY; Huang WJ; Chao SW; Chang YL; Chen CC
Clin Cancer Res; 2015 Jan; 21(2):428-38. PubMed ID: 25593344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
